Skip to content

Comparison of surfactant injection method in neonates with respiratory distress

Comparison of the less invasive surfactant administration (LISA) with the usual method of surfactant injection (INSURE) in respiratory distress syndrome in neonates

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201222049802N4
Enrollment
84
Registered
2024-05-07
Start date
2024-05-30
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory distress syndrome of newborn. Respiratory distress syndrome of newborn

Interventions

Intervention 1: Intervention group: Hospitalized neonates receive Beraksurf vial at a dose of 4 cc per kilogram by intratracheal method. Beraksurf is a natural surfactant. Each vial of Beraksurf (Bera

Sponsors

Zanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Months

Inclusion criteria

Inclusion criteria: Neonates with a gestational age less than or equal to 34 weeks Neonates who were not intubated at birth Neonates who are on non-invasive respiratory support at birth Moderate or severe respiratory distress FIO2 requirement greater than 40% need surfactant injection

Exclusion criteria

Exclusion criteria: Congenital abnormalities Congenital structural pulmonary disease Congenital heart disease neonates who underwent advanced resuscitation at birth neonates who were intubated due to severe respiratory distress at birth neonates with a gestational age of less than 26 weeks

Design outcomes

Primary

MeasureTime frame
The need for intubation in the first 72 hours of birth. Timepoint: The first 72 hours of birth. Method of measurement: Record patient file information.

Secondary

MeasureTime frame
Incidence of Pneumothorax. Timepoint: From patient admission to hospital discharge. Method of measurement: Clinical observation and chest x ray.;Duration requires Mechanical ventilation. Timepoint: From patient admission to hospital discharge. Method of measurement: Count the days required for a mechanical ventilation.;Incidence of pulmonary hemorrhage. Timepoint: From patient admission to hospital discharge. Method of measurement: Clinical observation and chest x ray.;Incidence of Intraventricular hemorrhage. Timepoint: At 7, 14 and 30 days if hospitalized. Method of measurement: Brain Sonography.;Need the next dose of Surfactant. Timepoint: The first three days of hospitalization. Method of measurement: Record patient file information.;Incidence of death. Timepoint: Incidence of death from admission to hospital discharge. Method of measurement: Physical examination.;Duration of hospitalization. Timepoint: At the time of discharge from the hospital. Method of measurement: Count the number of hospitalization days.;Duration of need for non-invasive ventilation. Timepoint: From patient admission to hospital discharge. Method of measurement: Number of days required for non-invasive ventilation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAsghar Marzban

Zanjan University of Medical Sciences

Drmarzban@zums.ac.ir+98 24 3313 1292

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026